ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

House Appropriator Claims NCI, NLM Grants Funded Political Activity, Seeks OIG Probe

March 22, 2013

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

GAO Suggest NIG Stop Automatic Funding Of Non Competing Grants, Pay Higher Percent Of New Grants

August 13, 1976

Study Identifies Risk Factors To Predict Contralateral Cancer

February 27, 2009

In Brief: Accidents Claim Wisconsin’s William Caldwell, John Wear; Murchison, Nance To Head Nalsi

June 15, 1979